{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T10:24:26Z","timestamp":1790418266689,"version":"4.1.0"},"reference-count":105,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T00:00:00Z","timestamp":1364774400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T00:00:00Z","timestamp":1364774400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Hematology"],"published-print":{"date-parts":[[2013,4]]},"DOI":"10.1053\/j.seminhematol.2013.03.028","type":"journal-article","created":{"date-parts":[[2013,6,11]],"date-time":"2013-06-11T10:55:09Z","timestamp":1370948109000},"page":"156-164","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":48,"title":["Aplastic Anemia: What Have We Learned From Animal Models and From the Clinic"],"prefix":"10.1053","volume":"50","author":[{"given":"Phillip","family":"Scheinberg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jichun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/j.seminhematol.2013.03.028_bib1","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1182\/blood-2011-12-274019","article-title":"How I treat acquired aplastic anemia","volume":"120","author":"Scheinberg","year":"2012","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2013.03.028_bib2","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1182\/blood.V64.5.1036.1036","article-title":"Busulfan-induced chronic bone marrow failure: changes in cortical bone, marrow stromal cells, and adherent cell colonies","volume":"64","author":"McManus","year":"1984","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2013.03.028_bib3","first-page":"47","article-title":"Benzene, artificial leather and aplastic anemia: Newark, 1916-1928","volume":"69","author":"Sharpe","year":"1993","journal-title":"Bull N Y Acad Med"},{"key":"10.1053\/j.seminhematol.2013.03.028_bib4","first-page":"357","article-title":"[Aplastic anemia: a model for its induction by oral and subcutaneous benzene in rats]","volume":"42","author":"Barrera Escorcia","year":"1997","journal-title":"Sangre (Barc)"},{"key":"10.1053\/j.seminhematol.2013.03.028_bib5","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0300-483X(01)00371-7","article-title":"A model for the induction of aplastic anemia by subcutaneous administration of benzene in mice","volume":"162","author":"Velasco Lezama","year":"2001","journal-title":"Toxicology"},{"key":"10.1053\/j.seminhematol.2013.03.028_bib6","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1046\/j.1365-2613.2003.00239.x","article-title":"A new model of busulphan-induced chronic bone marrow aplasia in the female BALB\/c mouse","volume":"84","author":"Gibson","year":"2003","journal-title":"Int J Exp Pathol"},{"key":"10.1053\/j.seminhematol.2013.03.028_bib7","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/S0278-6915(00)00087-9","article-title":"An assessment of chloramphenicol and thiamphenicol in the induction of aplastic anaemia in the BALB\/c mouse","volume":"38","author":"Turton","year":"2000","journal-title":"Food Chem Toxicol"},{"key":"10.1053\/j.seminhematol.2013.03.028_bib8","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1111\/j.1365-2141.1967.tb00758.x","article-title":"Aplastic anaemia in sublethally irradiated mice given allogeneic lymph node cells","volume":"13","author":"Barnes","year":"1967","journal-title":"Br J Haematol"},{"key":"10.1053\/j.seminhematol.2013.03.028_bib9","first-page":"791","article-title":"Experimental hypoplastic marrow failure in the mouse","volume":"6","author":"Kubota","year":"1978","journal-title":"Exp Hematol"},{"key":"10.1053\/j.seminhematol.2013.03.028_bib10","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1002\/stem.5530020406","article-title":"Experimental immunologically mediated aplastic anemia (AA) in mice: cyclosporin A fails to protect against AA","volume":"2","author":"Knospe","year":"1984","journal-title":"Int J Cell Cloning"},{"key":"10.1053\/j.seminhematol.2013.03.028_bib11","first-page":"269","article-title":"Immunologically mediated aplastic anemia in mice: effects of varying the source and composition of donor cells","volume":"15","author":"Chiu","year":"1987","journal-title":"Exp Hematol"},{"key":"10.1053\/j.seminhematol.2013.03.028_bib12","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/j.exphem.2004.08.006","article-title":"A mouse model of lymphocyte infusion-induced bone marrow failure","volume":"32","author":"Bloom","year":"2004","journal-title":"Exp Hematol"},{"key":"10.1053\/j.seminhematol.2013.03.028_bib13","first-page":"573","article-title":"Immunologically mediated aplastic anemia in mice: evidence of hematopoietic stromal injury and injury to hematopoietic stem cells","volume":"22","author":"Knospe","year":"1994","journal-title":"Exp Hematol"},{"key":"10.1053\/j.seminhematol.2013.03.028_bib14","first-page":"1047","article-title":"Successful bone marrow grafts in experimental aplastic anemia using antilymphocytic serum for conditioning","volume":"16","author":"Speck","year":"1971","journal-title":"Rev Eur Etud Clin Biol"},{"key":"10.1053\/j.seminhematol.2013.03.028_bib15","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1111\/j.1365-2141.1973.tb01701.x","article-title":"Paroxysmal nocturnal haemoglobinuria and refractory marrow failure treated by marrow transplantation","volume":"24","author":"Storb","year":"1973","journal-title":"Br J Haematol"},{"key":"10.1053\/j.seminhematol.2013.03.028_bib16","first-page":"355","article-title":"Marrow transplantation in aplastic anemia","volume":"6","author":"Storb","year":"1974","journal-title":"Transplant Proc"},{"key":"10.1053\/j.seminhematol.2013.03.028_bib17","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1136\/bmj.2.5702.131","article-title":"Bone marrow graft in man after conditioning by antilymphocytic serum","volume":"2","author":"Mathe","year":"1970","journal-title":"Br Med J"},{"key":"10.1053\/j.seminhematol.2013.03.028_bib18","first-page":"97","article-title":"Recovery from aplastic anemia following attempted marrow transplantation","volume":"4","author":"Thomas","year":"1976","journal-title":"Exp Hematol"},{"key":"10.1053\/j.seminhematol.2013.03.028_bib19","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1182\/blood-2006-03-010777","article-title":"Current concepts in the pathophysiology and treatment of aplastic anemia","volume":"108","author":"Young","year":"2006","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2013.03.028_bib20","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/BF01633873","article-title":"Further studies on experimental benzene induced aplastic anemia","volume":"25","author":"Kissling","year":"1972","journal-title":"Blut"},{"key":"10.1053\/j.seminhematol.2013.03.028_bib21","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1001\/jama.1976.03270100011005","article-title":"Aplastic anemia associated with gamma-benzene hexachloride","volume":"236","author":"Hans","year":"1976","journal-title":"JAMA"},{"key":"10.1053\/j.seminhematol.2013.03.028_bib22","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1056\/NEJM196312192692508","article-title":"Insecticides and aplastic anemia","volume":"269","author":"Sanchez Medal","year":"1963","journal-title":"N Engl J Med"},{"key":"10.1053\/j.seminhematol.2013.03.028_bib23","first-page":"650","article-title":"Studies on the development of bone marrow hypoplasia. I. Effects of benzene on blood and bone marrow","volume":"57","author":"Das","year":"1969","journal-title":"Indian J Med Res"},{"key":"10.1053\/j.seminhematol.2013.03.028_bib24","first-page":"296","article-title":"Haematological effects of chronic benzene poisoning in 217 workers","volume":"28","author":"Aksoy","year":"1971","journal-title":"Br J Ind Med"},{"key":"10.1053\/j.seminhematol.2013.03.028_bib25","first-page":"56","article-title":"Details of blood changes in 32 patients with pancytopenia associated with long-term exposure to benzene","volume":"29","author":"Aksoy","year":"1972","journal-title":"Br J Ind Med"},{"key":"10.1053\/j.seminhematol.2013.03.028_bib26","first-page":"192","article-title":"Occupational exposure to benzene in China","volume":"44","author":"Yin","year":"1987","journal-title":"Br J Ind Med"},{"key":"10.1053\/j.seminhematol.2013.03.028_bib27","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1080\/15287399509532028","article-title":"Differences in xenobiotic detoxifying activities between bone marrow stromal cells from mice and rats: implications for benzene-induced hematotoxicity","volume":"46","author":"Zhu","year":"1995","journal-title":"J Toxicol Environ Health"},{"key":"10.1053\/j.seminhematol.2013.03.028_bib28","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1080\/10915810701489697","article-title":"Amifostine protects bone marrow from benzene-induced hematotoxicity in mice","volume":"26","author":"Yu","year":"2007","journal-title":"Int J Toxicol"},{"key":"10.1053\/j.seminhematol.2013.03.028_bib29","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1182\/blood.V44.1.49.49","article-title":"An animal model of chronic aplastic marrow failure. I. Late marrow failure after busulfan","volume":"44","author":"Morley","year":"1974","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2013.03.028_bib30","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/j.0959-9673.2006.00455.x","article-title":"Further development of a model of chronic bone marrow aplasia in the busulphan-treated mouse","volume":"87","author":"Turton","year":"2006","journal-title":"Int J Exp Pathol"},{"key":"10.1053\/j.seminhematol.2013.03.028_bib31","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1111\/j.1365-2141.1976.tb00955.x","article-title":"Residual marrow damage: possible explanation for idiosyncrasy to chloramphenicol","volume":"32","author":"Morley","year":"1976","journal-title":"Br J Haematol"},{"key":"10.1053\/j.seminhematol.2013.03.028_bib32","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/bjc.1975.149","article-title":"Reduced lethality in mice receiving a combined dose of cyclophosphamide and busulphan","volume":"32","author":"Millar","year":"1975","journal-title":"Br J Cancer"},{"key":"10.1053\/j.seminhematol.2013.03.028_bib33","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1191\/096032799678845098","article-title":"Haemotoxicity of chloramphenicol succinate in the CD-1 mouse and Wistar Hanover rat","volume":"18","author":"Turton","year":"1999","journal-title":"Hum Exp Toxicol"},{"key":"10.1053\/j.seminhematol.2013.03.028_bib34","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/j.0959-9673.2006.00460.x","article-title":"Characterization of the myelotoxicity of chloramphenicol succinate in the B6C3F1 mouse","volume":"87","author":"Turton","year":"2006","journal-title":"Int J Exp Pathol"},{"key":"10.1053\/j.seminhematol.2013.03.028_bib35","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1001\/jama.1964.03060320053013","article-title":"Drug-induced blood dyscrasias. I. Aplastic anemia","volume":"188","author":"Erslev","year":"1964","journal-title":"JAMA"},{"key":"10.1053\/j.seminhematol.2013.03.028_bib36","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/0272-0590(90)90183-K","article-title":"Comparison of the activity of topically applied pesticides and the herbicide 2,4-D in two short-term in vivo assays of genotoxicity in the mouse","volume":"15","author":"Schop","year":"1990","journal-title":"Fundam Appl Toxicol"},{"key":"10.1053\/j.seminhematol.2013.03.028_bib37","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1182\/blood-2005-01-0161","article-title":"The epidemiology of aplastic anemia in Thailand","volume":"107","author":"Issaragrisil","year":"2006","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2013.03.028_bib38","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.cbi.2010.03.049","article-title":"Immunosuppressive therapy of cyclosporin A for severe benzene-induced haematopoietic disorders and a 6-month follow-up","volume":"186","author":"Song","year":"2010","journal-title":"Chem Biol Interact"},{"key":"10.1053\/j.seminhematol.2013.03.028_bib39","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/j.1365-2141.1988.tb04238.x","article-title":"Treatment of gold-induced aplastic anaemia with immunosuppressive therapy","volume":"68","author":"Doney","year":"1988","journal-title":"Br J Haematol"},{"key":"10.1053\/j.seminhematol.2013.03.028_bib40","doi-asserted-by":"crossref","first-page":"695","DOI":"10.7326\/0003-4819-109-9-695","article-title":"Epstein-Barr virus in the bone marrow of patients with aplastic anemia","volume":"109","author":"Baranski","year":"1988","journal-title":"Ann Intern Med"},{"key":"10.1053\/j.seminhematol.2013.03.028_bib41","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1056\/NEJM199704103361504","article-title":"Hepatitis-associated aplastic anemia","volume":"336","author":"Brown","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1053\/j.seminhematol.2013.03.028_bib42","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1093\/hmg\/ddp556","article-title":"FANCC suppresses short telomere-initiated telomere sister chromatid exchange","volume":"19","author":"Rhee","year":"2010","journal-title":"Hum Mol Genet"},{"key":"10.1053\/j.seminhematol.2013.03.028_bib43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1182\/blood.V94.1.1.413k03_1_8","article-title":"Loss of FancC function results in decreased hematopoietic stem cell repopulating ability","volume":"94","author":"Haneline","year":"1999","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2013.03.028_bib44","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1634\/stemcells.20-5-438","article-title":"Hematopoietic stem cells from fancc(-\/-) mice have lower growth and differentiation potential in response to growth factors","volume":"20","author":"Aube","year":"2002","journal-title":"Stem Cells"},{"key":"10.1053\/j.seminhematol.2013.03.028_bib45","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1182\/blood-2004-08-3033","article-title":"Hypoxia-reoxygenation induces premature senescence in FA bone marrow hematopoietic cells","volume":"106","author":"Zhang","year":"2005","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2013.03.028_bib46","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/nature10192","article-title":"Fancd2 counteracts the toxic effects of naturally produced aldehydes in mice","volume":"475","author":"Langevin","year":"2011","journal-title":"Nature"},{"key":"10.1053\/j.seminhematol.2013.03.028_bib47","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1038\/nature11368","article-title":"Genotoxic consequences of endogenous aldehydes on mouse haematopoietic stem cell function","volume":"489","author":"Garaycoechea","year":"2012","journal-title":"Nature"},{"key":"10.1053\/j.seminhematol.2013.03.028_bib48","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1182\/asheducation-2011.1.480","article-title":"Dyskeratosis congenita","volume":"2011","author":"Dokal","year":"2011","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"10.1053\/j.seminhematol.2013.03.028_bib49","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1126\/science.1079447","article-title":"Dyskeratosis congenita and cancer in mice deficient in ribosomal RNA modification","volume":"299","author":"Ruggero","year":"2003","journal-title":"Science"},{"key":"10.1053\/j.seminhematol.2013.03.028_bib50","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1111\/j.1399-0004.2007.00923.x","article-title":"Dyskeratosis congenita: a genetic disorder of many faces","volume":"73","author":"Kirwan","year":"2008","journal-title":"Clin Genet"},{"key":"10.1053\/j.seminhematol.2013.03.028_bib51","doi-asserted-by":"crossref","first-page":"6549","DOI":"10.1182\/blood-2008-12-192880","article-title":"Cancer in dyskeratosis congenita","volume":"113","author":"Alter","year":"2009","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2013.03.028_bib52","doi-asserted-by":"crossref","first-page":"10148","DOI":"10.1073\/pnas.0913125107","article-title":"Telomere length is inherited with resetting of the telomere set-point","volume":"107","author":"Chiang","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1053\/j.seminhematol.2013.03.028_bib53","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1101\/gad.1679208","article-title":"Engineered telomere degradation models dyskeratosis congenita","volume":"22","author":"Hockemeyer","year":"2008","journal-title":"Genes Dev"},{"key":"10.1053\/j.seminhematol.2013.03.028_bib54","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1006\/geno.1994.1544","article-title":"Molecular cloning of murine pig-a, a gene for GPI-anchor biosynthesis, and demonstration of interspecies conservation of its structure, function, and genetic locus","volume":"23","author":"Kawagoe","year":"1994","journal-title":"Genomics"},{"key":"10.1053\/j.seminhematol.2013.03.028_bib55","doi-asserted-by":"crossref","first-page":"7938","DOI":"10.1073\/pnas.93.15.7938","article-title":"A knock-out model of paroxysmal nocturnal hemoglobinuria: Pig-a(-) hematopoiesis is reconstituted following intercellular transfer of GPI-anchored proteins","volume":"93","author":"Dunn","year":"1996","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1053\/j.seminhematol.2013.03.028_bib56","doi-asserted-by":"crossref","first-page":"3600","DOI":"10.1182\/blood.V87.9.3600.bloodjournal8793600","article-title":"Glycosylphosphatidylinositol-anchor-deficient mice: implications for clonal dominance of mutant cells in paroxysmal nocturnal hemoglobinuria","volume":"87","author":"Kawagoe","year":"1996","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2013.03.028_bib57","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1172\/JCI119613","article-title":"Murine embryonic stem cells without pig-a gene activity are competent for hematopoiesis with the PNH phenotype but not for clonal expansion","volume":"100","author":"Rosti","year":"1997","journal-title":"J Clin Invest"},{"key":"10.1053\/j.seminhematol.2013.03.028_bib58","doi-asserted-by":"crossref","first-page":"2945","DOI":"10.1182\/blood.V94.9.2945","article-title":"Increased sensitivity to complement and a decreased red blood cell life span in mice mosaic for a nonfunctional Piga gene","volume":"94","author":"Tremml","year":"1999","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2013.03.028_bib59","doi-asserted-by":"crossref","first-page":"2963","DOI":"10.1182\/blood.V94.9.2963","article-title":"Different roles of glycosylphosphatidylinositol in various hematopoietic cells as revealed by a mouse model of paroxysmal nocturnal hemoglobinuria","volume":"94","author":"Murakami","year":"1999","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2013.03.028_bib60","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1084\/jem.194.5.581","article-title":"FES-Cre targets phosphatidylinositol glycan class A (PIGA) inactivation to hematopoietic stem cells in the bone marrow","volume":"194","author":"Keller","year":"2001","journal-title":"J Exp Med"},{"key":"10.1053\/j.seminhematol.2013.03.028_bib61","doi-asserted-by":"crossref","first-page":"2248","DOI":"10.1182\/blood.V98.7.2248","article-title":"GATA1-Cre mediates Piga gene inactivation in the erythroid\/megakaryocytic lineage and leads to circulating red cells with a partial deficiency in glycosyl phosphatidylinositol-linked proteins (paroxysmal nocturnal hemoglobinuria type II cells)","volume":"98","author":"Jasinski","year":"2001","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2013.03.028_bib62","doi-asserted-by":"crossref","first-page":"214","DOI":"10.3324\/haematol.2009.011650","article-title":"Phenotypic and functional characterization of a mouse model of targeted Pig-a deletion in hematopoietic cells","volume":"95","author":"Visconte","year":"2010","journal-title":"Haematologica"},{"key":"10.1053\/j.seminhematol.2013.03.028_bib63","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1046\/j.1365-2141.2003.04190.x","article-title":"High-dose cyclophosphamide does not eradicate paroxysmal nocturnal haemoglobinuria haematopoiesis in mice carrying a Piga gene mutation","volume":"120","author":"Schaefer","year":"2003","journal-title":"Br J Haematol"},{"key":"10.1053\/j.seminhematol.2013.03.028_bib64","first-page":"457","article-title":"Analysis of the histocompatibility-2 locus in the mouse","volume":"14","author":"Snell","year":"1953","journal-title":"J Natl Cancer Inst"},{"key":"10.1053\/j.seminhematol.2013.03.028_bib65","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1093\/genetics\/36.3.306","article-title":"Alleles at the histocompatibility-2 locus in the mouse as determined by tumor transplantation","volume":"36","author":"Snell","year":"1951","journal-title":"Genetics"},{"key":"10.1053\/j.seminhematol.2013.03.028_bib66","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1056\/NEJM195709122571102","article-title":"Intravenous infusion of bone marrow in patients receiving radiation and chemotherapy","volume":"257","author":"Thomas","year":"1957","journal-title":"N Engl J Med"},{"key":"10.1053\/j.seminhematol.2013.03.028_bib67","first-page":"516","article-title":"Successful marrow homograft in the dog after radiation","volume":"43","author":"Ferrebee","year":"1958","journal-title":"Surgery"},{"key":"10.1053\/j.seminhematol.2013.03.028_bib68","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1182\/blood.V20.6.730.730","article-title":"Recovery of lethally irradiated dogs following infusion of autologous marrow stored at low temperature in dimethylsulphoxide","volume":"20","author":"Cavins","year":"1962","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2013.03.028_bib69","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1038\/1961110a0","article-title":"Prevention of delayed foreign marrow reaction in lethally irradiated mice by early administration of methotrexate","volume":"196","author":"Lochte","year":"1962","journal-title":"Nature"},{"key":"10.1053\/j.seminhematol.2013.03.028_bib70","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1182\/blood.V21.4.424.424","article-title":"Infusion of marrow in the mouse and dog after thio-TEPA","volume":"21","author":"Lochte","year":"1963","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2013.03.028_bib71","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1056\/NEJM196607142750209","article-title":"Treatment of bone-marrow failure by isogeneic marrow infusion","volume":"275","author":"Pillow","year":"1966","journal-title":"N Engl J Med"},{"key":"10.1053\/j.seminhematol.2013.03.028_bib72","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1182\/blood.V43.2.157.157","article-title":"Allogeneic marrow grafting for treatment of aplastic anemia","volume":"43","author":"Storb","year":"1974","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2013.03.028_bib73","first-page":"913","article-title":"Aplastic anemia treated by marrow transplantation","volume":"5","author":"Buckner","year":"1973","journal-title":"Transplant Proc"},{"key":"10.1053\/j.seminhematol.2013.03.028_bib74","first-page":"545","article-title":"Therapy of experimental immunologically mediated aplastic anemia in mice by various immunosuppressive and antitumor agents","volume":"20","author":"Nemoto","year":"1988","journal-title":"Transplant Proc"},{"key":"10.1053\/j.seminhematol.2013.03.028_bib75","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1182\/blood-2004-03-1115","article-title":"Bystander destruction of hematopoietic progenitor and stem cells in a mouse model of infusion-induced bone marrow failure","volume":"104","author":"Chen","year":"2004","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2013.03.028_bib76","doi-asserted-by":"crossref","first-page":"4159","DOI":"10.4049\/jimmunol.178.7.4159","article-title":"Minor antigen h60-mediated aplastic anemia is ameliorated by immunosuppression and the infusion of regulatory T cells","volume":"178","author":"Chen","year":"2007","journal-title":"J Immunol"},{"key":"10.1053\/j.seminhematol.2013.03.028_bib77","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1182\/blood-2009-03-211383","article-title":"The role of the Th1 transcription factor T-bet in a mouse model of immune-mediated bone-marrow failure","volume":"115","author":"Tang","year":"2010","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2013.03.028_bib78","doi-asserted-by":"crossref","first-page":"4175","DOI":"10.1182\/blood-2010-01-266098","article-title":"Th17 immune responses contribute to the pathophysiology of aplastic anemia","volume":"116","author":"de Latour","year":"2010","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2013.03.028_bib79","doi-asserted-by":"crossref","first-page":"3414","DOI":"10.4049\/jimmunol.0801430","article-title":"Lymphocytes with aberrant expression of Fas or Fas ligand attenuate immune bone marrow failure in a mouse model","volume":"182","author":"Omokaro","year":"2009","journal-title":"J Immunol"},{"key":"10.1053\/j.seminhematol.2013.03.028_bib80","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.exphem.2008.12.001","article-title":"Role of perforin-mediated cell apoptosis in murine models of infusion-induced bone marrow failure","volume":"37","author":"Sarcon","year":"2009","journal-title":"Exp Hematol"},{"key":"10.1053\/j.seminhematol.2013.03.028_bib81","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1038\/nature10160","article-title":"In vivo imaging of Treg cells providing immune privilege to the haematopoietic stem-cell niche","volume":"474","author":"Fujisaki","year":"2011","journal-title":"Nature"},{"key":"10.1053\/j.seminhematol.2013.03.028_bib82","doi-asserted-by":"crossref","first-page":"3921","DOI":"10.1182\/blood-2010-10-311894","article-title":"Tregs prevent GVHD and promote immune reconstitution in HLA-haploidentical transplantation","volume":"117","author":"Di Ianni","year":"2011","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2013.03.028_bib83","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1182\/blood-2010-07-293795","article-title":"Infusion of ex vivo expanded T regulatory cells in adults transplanted with umbilical cord blood: safety profile and detection kinetics","volume":"117","author":"Brunstein","year":"2011","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2013.03.028_bib84","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1056\/NEJMoa1108188","article-title":"Interleukin-2 and regulatory T cells in graft-versus-host disease","volume":"365","author":"Koreth","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1053\/j.seminhematol.2013.03.028_bib85","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1056\/NEJMoa1105143","article-title":"Regulatory T-cell responses to low-dose interleukin-2 in HCV-induced vasculitis","volume":"365","author":"Saadoun","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1053\/j.seminhematol.2013.03.028_bib86","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/nature08099","article-title":"Bone-marrow adipocytes as negative regulators of the haematopoietic microenvironment","volume":"460","author":"Naveiras","year":"2009","journal-title":"Nature"},{"key":"10.1053\/j.seminhematol.2013.03.028_bib87","doi-asserted-by":"crossref","first-page":"e41","DOI":"10.1182\/blood-2010-02-268466","article-title":"Hematopoiesis in 3 dimensions: human and murine bone marrow architecture visualized by confocal microscopy","volume":"116","author":"Takaku","year":"2010","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2013.03.028_bib88","doi-asserted-by":"crossref","first-page":"2236","DOI":"10.1182\/blood-2008-09-178871","article-title":"Sex hormones, acting on the TERT gene, increase telomerase activity in human primary hematopoietic cells","volume":"114","author":"Calado","year":"2009","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2013.03.028_bib89","doi-asserted-by":"crossref","first-page":"4446","DOI":"10.1182\/blood-2007-08-019729","article-title":"Telomere maintenance and human bone marrow failure","volume":"111","author":"Calado","year":"2008","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2013.03.028_bib90","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1073\/pnas.82.1.188","article-title":"Interferon is a mediator of hematopoietic suppression in aplastic anemia in vitro and possibly in vivo","volume":"82","author":"Zoumbos","year":"1985","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1053\/j.seminhematol.2013.03.028_bib91","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1056\/NEJM198501313120501","article-title":"Circulating activated suppressor T lymphocytes in aplastic anemia","volume":"312","author":"Zoumbos","year":"1985","journal-title":"N Engl J Med"},{"key":"10.1053\/j.seminhematol.2013.03.028_bib92","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1182\/blood-2007-01-066258","article-title":"Deficient CD4+ CD25+ FOXP3+ T regulatory cells in acquired aplastic anemia","volume":"110","author":"Solomou","year":"2007","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2013.03.028_bib93","doi-asserted-by":"crossref","first-page":"4175","DOI":"10.1182\/blood-2010-01-266098","article-title":"Th17 immune responses contribute to the pathophysiology of aplastic anemia","volume":"116","author":"Peffault de Latour","year":"2010","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2013.03.028_bib94","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1182\/blood-2011-11-390708","article-title":"Intrinsic impairment of CD4+CD25+ regulatory T cells in acquired aplastic anemia","volume":"120","author":"Shi","year":"2012","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2013.03.028_bib95","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S0140-6736(04)16724-X","article-title":"In-vivo dominant immune responses in aplastic anaemia: molecular tracking of putatively pathogenetic T-cell clones by TCR beta-CDR3 sequencing","volume":"364","author":"Risitano","year":"2004","journal-title":"Lancet"},{"key":"10.1053\/j.seminhematol.2013.03.028_bib96","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1056\/NEJM199105093241901","article-title":"Treatment of aplastic anemia with antilymphocyte globulin and methylprednisolone with or without cyclosporine. The German Aplastic Anemia Study Group","volume":"324","author":"Frickhofen","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1053\/j.seminhematol.2013.03.028_bib97","doi-asserted-by":"crossref","first-page":"4434","DOI":"10.1182\/blood-2010-08-304071","article-title":"A randomized controlled study in patients with newly diagnosed severe aplastic anemia receiving antithymocyte globulin (ATG), cyclosporine, with or without G-CSF: a study of the SAA Working Party of the European Group for Blood and Marrow Transplantation","volume":"117","author":"Tichelli","year":"2011","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2013.03.028_bib98","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1111\/j.1365-2141.2006.06085.x","article-title":"Treatment of severe aplastic anaemia with combined immunosuppression: anti-thymocyte globulin, ciclosporin and mycophenolate mofetil","volume":"133","author":"Scheinberg","year":"2006","journal-title":"Br J Haematol"},{"key":"10.1053\/j.seminhematol.2013.03.028_bib99","doi-asserted-by":"crossref","first-page":"348","DOI":"10.3324\/haematol.13829","article-title":"Treatment of severe aplastic anemia with a combination of horse antithymocyte globulin and cyclosporine, with or without sirolimus: a prospective randomized study","volume":"94","author":"Scheinberg","year":"2009","journal-title":"Haematologica"},{"key":"10.1053\/j.seminhematol.2013.03.028_bib100","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1056\/NEJMoa1103975","article-title":"Horse versus rabbit antithymocyte globulin in acquired aplastic anemia","volume":"365","author":"Scheinberg","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1053\/j.seminhematol.2013.03.028_bib101","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1182\/blood-2011-05-352328","article-title":"Activity of alemtuzumab monotherapy in treatment-naive, relapsed, and refractory severe acquired aplastic anemia","volume":"119","author":"Scheinberg","year":"2012","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2013.03.028_bib102","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1016\/S0140-6736(00)03126-3","article-title":"High-dose cyclophosphamide in severe aplastic anaemia: a randomised trial","volume":"356","author":"Tisdale","year":"2000","journal-title":"Lancet"},{"key":"10.1053\/j.seminhematol.2013.03.028_bib103","doi-asserted-by":"crossref","first-page":"382","DOI":"10.3324\/haematol.2009.013557","article-title":"Long-term follow-up of patients with moderate aplastic anemia and pure red cell aplasia treated with daclizumab","volume":"95","author":"Sloand","year":"2010","journal-title":"Haematologica"},{"key":"10.1053\/j.seminhematol.2013.03.028_bib104","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1200931","article-title":"Eltrombopag and improved hematopoiesis in refractory aplastic anemia","volume":"367","author":"Olnes","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1053\/j.seminhematol.2013.03.028_bib105","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0037-1963(00)90032-5","article-title":"Hematopoietic growth factors in the pathogenesis and for the treatment of aplastic anemia","volume":"37","author":"Marsh","year":"2000","journal-title":"Semin Hematol"}],"container-title":["Seminars in Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0037196313000528?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0037196313000528?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T06:23:22Z","timestamp":1758522202000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0037196313000528"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4]]},"references-count":105,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,4]]}},"alternative-id":["S0037196313000528"],"URL":"https:\/\/doi.org\/10.1053\/j.seminhematol.2013.03.028","relation":{},"ISSN":["0037-1963"],"issn-type":[{"value":"0037-1963","type":"print"}],"subject":[],"published":{"date-parts":[[2013,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Aplastic Anemia: What Have We Learned From Animal Models and From the Clinic","name":"articletitle","label":"Article Title"},{"value":"Seminars in Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.seminhematol.2013.03.028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}